Integrating molecular profiling into current clinical stratification could improve outcomes in rhabdomyosarcoma, according to researchers.
The test can accurately detect cancer and predict where it is located, according to researchers.
Dr Alan Lyss reviews studies of KRAS G12C mutations in metastatic colorectal cancer.
The study showed differences by cancer type and race/ethnicity.
Two experts discuss the future of colorectal cancer screening and lessons learned during the era of COVID-19.
Education, communication, and coordination are key.
The current scientific evidence may not be generalizable to underrepresented groups.
Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures.
Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.
Results from the BOOSTER trial add to data suggesting no benefit with osimertinib in combination over osimertinib alone.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Experts outline treatment options and make recommendations.
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.